Discover 1,955 paid clinical trials in Plano, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,955
O. Formigenes Colonization in Calcium Oxalate Kidney Stone Disease
for
Kidney Stone, Kidney Calculi, Urolithiasis,
Location: Dallas TX, Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18 - 70+
Code: NCT06330246
Recruiting
Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
for
AL Amyloidosis, Amyloidosis
Location: Dallas TX, Nashville TN
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 18+
Code: NCT05145816
Phase 1, Phase 2, Recruiting
Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias
for
Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 2,
Location: Dallas TX, Houston TX, Atlanta GA, Chicago IL,
Sponsor: Lauren Moore
Sex: All
Age: 6+
Code: NCT01060371
Recruiting
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
for
Movement Disorders, Neurology, Parkinsons Disease
Location: Dallas TX, Baltimore MD, Philadelphia PA, New York NY
Sponsor: InSightec
Sex: All
Age: 30 - 70+
Code: NCT05539196
Recruiting
Deep Brain Stimulation for Psychosis
for
Treatment-Refractory Schizophrenia
Location: Dallas TX
Sponsor: Bradley Lega
Sex: All
Age: 22 - 70
Code: NCT06257056
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
for
Langerhans Cell Histiocytosis
Location: Fort Worth TX, Austin TX, Houston TX, San Antonio TX,
Sponsor: Baylor College of Medicine
Sex: All
Age: 0 - 21
Code: NCT02670707
Phase 3, Recruiting
AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom)
for
Phenylketonurias
Location: Dallas TX, Minneapolis MN, Pittsburgh PA, Orange CA,
Sponsor: NGGT INC.
Sex: All
Age: 18 - 55
Code: NCT06332807
Phase 1, Phase 2, Recruiting
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
for
Hodgkin Lymphoma in Remission, Leukemia in Remission,
Location: Dallas TX, Oklahoma City OK, Houston TX, San Antonio TX,
Sponsor: Children's Oncology Group
Sex: All
Age: 0+
Code: NCT01790152
Recruiting
Dual Antiplatelet Therapy (DAPT) in Patients With Baseline Thrombocytopenia
for
Baseline Thrombocytopenia
Location: Dallas TX
Sponsor: Methodist Health System
Sex: All
Age: 18+
Code: NCT06223607
Recruiting
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
Screening Emotions in Adolescents at the Hospital for mTBI
for
Brain Injury Traumatic Mild, Brain Injuries,
Location: Dallas TX, Houston TX, Milwaukee WI, Philadelphia PA,
Sponsor: University of California, Davis
Sex: All
Age: 11 - 17
Code: NCT06370520
Recruiting
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
for
Breast Cancer, Solid Tumors, Adult
Location: Dallas TX, Houston TX, San Antonio TX, Germantown TN,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT05768139
Phase 1, Phase 2, Recruiting
Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Irving TX, Houston TX, San Antonio TX, Aurora CO,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All
Age: 18+
Code: NCT06384352
Phase 1, Recruiting
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Dallas TX, Houston TX, San Antonio TX, Baton Rouge LA,
Sponsor: Kartos Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06479135
Phase 3, Recruiting
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)